Febentel 150 mg

Fenbendazole is used to control susceptible parasitic worm infections. Depending on the species and supplied product instructions, its antiparasitic activity covers:

• Roundworms

• Hookworms

• Whipworms

• Certain tapeworms

• Selected gastrointestinal worms

• Other susceptible parasites

Some people use fenbendazole off-label for cancer after laboratory studies reported activity involving:

• Cancer-cell division

• Microtubule formation

• Glucose uptake

• Cellular energy production

• Proteins controlling damaged cells

• Cancer-cell survival

A 2018 laboratory study reported effects on human cancer cells and reduced tumour growth in a mouse model. These findings explain the research interest but do not confirm that Febentel 150 mg treats or cures cancer in people.

Fenbendazole has also been included in computational COVID-19 research. Scientists examined whether fenbendazole and related compounds could interact with proteins involved in SARS-CoV-2 infection. No human clinical study has established Febentel 150 mg as a treatment for COVID-19.

Febentel 150 mg should not replace surgery, chemotherapy, radiotherapy, immunotherapy, antiviral treatment or another therapy recommended by a healthcare team.

The established benefit of fenbendazole is its broad activity against susceptible parasitic worms. It acts on processes the worms need to produce energy and survive.

Researchers are also examining fenbendazole because laboratory studies reported activity across several cellular pathways. Potential areas of research include:

• Interfering with cancer-cell division

• Disrupting microtubule function

• Reducing glucose uptake by cancer cells

• Affecting cellular energy production

• Activating pathways linked to cancer-cell death

• Supporting further drug-repurposing research

COVID-19 research involving fenbendazole has remained at an early computational stage. These studies can identify compounds for further laboratory testing, but they cannot confirm that a medicine prevents infection, improves symptoms or speeds recovery in people.

The research benefits listed above remain investigational. They should not be presented as confirmed treatment benefits for cancer or COVID-19.

For susceptible parasitic worms, fenbendazole binds to a structural protein called beta-tubulin and disrupts the formation of microtubules. Microtubules support essential functions inside parasite cells, including nutrient absorption and movement of cellular materials.

Without working microtubules, the worms cannot absorb and use glucose normally. Their energy reserves become depleted, causing them to lose function and die.

In cancer research, scientists are studying similar effects on microtubules inside rapidly dividing cancer cells. Laboratory research has also reported reduced glucose uptake, changes involving the p53 protein and disruption of enzymes used for cellular energy production. These combined effects contributed to cancer-cell death in experimental models.

For COVID-19 research, computer-based studies have examined how fenbendazole and other benzimidazoles interact with SARS-CoV-2 proteins. Computer predictions require laboratory and human testing before any clinical benefit can be determined.

The 150 mg stated on the pack describes the amount of fenbendazole in each tablet. It does not establish a suitable dose for a person, cancer type or COVID-19 infection.

There is no established human cancer or COVID-19 dosage for Febentel 150 mg. Online schedules recommending daily doses, treatment cycles or combinations with vitamins and supplements have not been validated through controlled human trials.

For its established antiparasitic use, dosing depends on the species, body weight, parasite and supplied product instructions. One product schedule should not be copied for another species or condition.

Do not select a dose based on online testimonials, tablet strength or another person’s experience. Anyone considering or already using fenbendazole should tell their healthcare team the exact product, strength, amount and frequency. Prescribed cancer or COVID-19 treatment should not be stopped, delayed or changed.

Common Side Effects: Reliable information about common side effects in people is unavailable because fenbendazole has not undergone sufficient human safety studies. Digestive discomfort, nausea, diarrhoea and allergic symptoms have been discussed in connection with benzimidazole medicines, but their frequency with Febentel 150 mg cannot be stated accurately.

Serious Side Effects: Published case reports have connected self-administered fenbendazole with drug-induced liver injury. Warning signs include yellow skin or eyes, dark urine, persistent nausea, loss of appetite, unusual tiredness and pain in the upper-right abdomen. Severe rash, facial swelling or breathing difficulty also requires urgent medical attention.

Febentel 150 mg should not be used for cancer or COVID-19 self-treatment. Particular concern applies to:

• People with liver disease

• People with abnormal liver tests

• People receiving chemotherapy

• People receiving immunotherapy

• People using antiviral treatment

• Pregnant or breastfeeding women

• Children and adolescents

• People allergic to benzimidazoles

• People enrolled in clinical trials

Human interaction studies involving fenbendazole are limited. Tell the healthcare team about every medicine, supplement and herbal product being used.

Important combinations requiring medical review include:

• Chemotherapy medicines

• Immunotherapy medicines

• Targeted cancer treatments

• Hormonal cancer treatments

• Antiviral medicines

• Liver-affecting medicines

• Other benzimidazole medicines

• Herbal remedies and supplements

Taking an undisclosed product can make it harder to determine whether liver-test changes or side effects are being caused by fenbendazole, prescribed treatment or an interaction between them.

• Keep the tablets in their original packaging.

• Follow the storage temperature printed on the pack.

• Protect them from heat and moisture.

• Keep them away from direct sunlight.

• Store them away from children and pets.

• Do not use tablets from damaged packaging.

• Check the batch number and expiry date.

• Dispose of expired tablets according to local requirements.